We use cookies to deliver our online services. Details of the cookies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you agree to our use of cookies. To close this message click close.


07 October 2014
On 25 September 2014 the UK Medicines and Healthcare Products Regulatory Agency ("MHRA") announced new simplified guidance for healthcare professionals reporting suspected adverse drug reactions ("ADR") in children in the UK.

The MHRA conducted a recent workshop with paediatric specialists, healthcare professionals and patient organisations, to assess ADR reporting in children. The workshop concluded that ADR reporting in children was "impractical for busy healthcare professionals and potentially acted as a barrier to reporting".

As a consequence, the MHRA guidance for healthcare professionals reporting ADR in children has been simplified to bring them into line with reporting guidelines for adults. Healthcare professionals must now report all suspected ADRs that are serious, medically significant or result in harm, but need not report less serious or minor ADRs. Healthcare professionals must continue to report all reactions associated with newer medicinal products identified with the black triangle symbol (▼).

This guidance applies to medicinal products, vaccines, herbal or complementary products, whether self-medicated or prescribed, and includes suspected ADRs associated with misuse and unlicensed medicines.

The MHRA hopes that the new guidelines will simplify and speed up the ADR reporting process for children.

EMA to Revise Herbal Medicines Guideline

On 1 September 2016, the European Medicines Agency ("EMA") opened for public consultation a Draft revision to its Guideline on the assessment of clinical safety and efficacy in the...

08 September 2016
Loading data